Table 1.
Descriptive characteristics and number and percent with diabetes for 1 068 098 between SEER‐Medicare cancer patients ages 66+ y diagnosed 2000 and 2011 for 14 cancers and matched individuals without cancer in the 5% random sample
| Characteristic | All cancers | Individuals without cancer | ||||
|---|---|---|---|---|---|---|
| Total | With diabetes | Total | With diabetes | |||
| N | N | % | N | N | % | |
| Total | 1 068 098 | 237 049 | 22.2 | 100 000 | 19 722 | 19.7 |
| Age, y | ||||||
| 66‐69 | 210 141 | 44 779 | 21.3 | 19 673 | 3,689 | 18.8 |
| 70‐74 | 267 815 | 61 610 | 23.0 | 25 076 | 5040 | 20.1 |
| 75‐79 | 247 548 | 58 104 | 23.5 | 23 176 | 4899 | 21.1 |
| 80‐84 | 188 056 | 42 639 | 22.7 | 17 605 | 3651 | 20.7 |
| 85+ | 154 538 | 29 917 | 19.4 | 14 470 | 2443 | 16.9 |
| Race/ethnicity | ||||||
| White | 973 300 | 207 537 | 21.3 | 91 121 | 17 094 | 18.8 |
| Black | 94 798 | 29 512 | 31.1 | 8879 | 2628 | 29.6 |
| Sex | ||||||
| Male | 564 980 | 127 070 | 22.5 | 52 897 | 10 984 | 20.8 |
| Female | 503 118 | 109 979 | 21.9 | 47 103 | 8738 | 18.6 |
| Stage at diagnosis | ||||||
| In situ | 29 588 | 7171 | 24.2 | ~ | ~ | ~ |
| Localized | 461 077 | 98 191 | 21.3 | ~ | ~ | ~ |
| Regional | 194 016 | 43 991 | 22.7 | ~ | ~ | ~ |
| Distant | 228 192 | 51 462 | 22.6 | ~ | ~ | ~ |
| Unknown/unstaged | 155 225 | 36 234 | 23.3 | ~ | ~ | ~ |
| Cancer sites | ||||||
| Bladder | 60 381 | 14 199 | 23.5 | ~ | ~ | ~ |
| Cervix | 3,373 | 743 | 22.0 | ~ | ~ | ~ |
| Colon/Rectum | 125 909 | 29 531 | 23.5 | ~ | ~ | ~ |
| Corpus/Uterus | 25 247 | 6488 | 25.7 | ~ | ~ | ~ |
| Female breast | ||||||
| ER positive | 89 278 | 17 753 | 19.9 | ~ | ~ | ~ |
| ER negative | 16 817 | 3510 | 20.9 | ~ | ~ | ~ |
| Hodgkin lymphoma | 1989 | 497 | 25.0 | ~ | ~ | ~ |
| Liver | 10 157 | 4276 | 42.1 | ~ | ~ | ~ |
| Myeloma | 15 890 | 3647 | 23.0 | ~ | ~ | ~ |
| Non‐Hodgkin lymphoma | 44 566 | 9781 | 21.9 | ~ | ~ | ~ |
| Ovary | 15 419 | 2948 | 19.1 | ~ | ~ | ~ |
| Pancreas | 34 058 | 11 928 | 35.0 | ~ | ~ | ~ |
| Prostate | 195 167 | 36 720 | 18.8 | ~ | ~ | ~ |
| Stomach | 18 056 | 4945 | 27.4 | ~ | ~ | ~ |
| Other | 411 791 | 90 083 | 21.9 | ~ | ~ | ~ |
ER, estrogen receptor.
A random sample of 100 000 individuals (controls) was chosen by frequency matching to all the sites combined cancer cohort by calendar year, age, and sex.
Controls can be sampled only once in a calendar year but can be sampled repeatedly across multiple years.
Other cancers include all reportable cancers made to SEER not individually specified as a separate cohort in this study.